Related Experiment Video
Updated: Jul 6, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Outcomes of COVID-19 patients undergoing extracorporeal membrane oxygenation: A systematic review and meta-Analysis
Shouliang Jiang1, Ping Yan2, Zhongyang Ma1
1Department of Pediatrics, West China Second University Hospital, Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Sichuan University, Chengdu, China.
Insights
This systematic review found that Coronavirus Disease 2019 patients receiving extracorporeal membrane oxygenation (ECMO) had a 66% survival probability. Key complications included renal injury (44%) and venous thrombosis (31%).
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- The Coronavirus Disease 2019 (COVID-19) pandemic necessitated advanced respiratory support strategies.
- Extracorporeal membrane oxygenation (ECMO) emerged as a critical intervention for severe COVID-19 cases.
- Understanding ECMO's efficacy and associated risks is vital for patient management.
Approach:
- A systematic review and meta-analysis was performed using PICOS criteria.
- Searched PubMed, Web of Science, and EMBASE databases for studies up to December 10, 2022.
- Employed random-effects meta-analysis and subgroup analysis, assessing study quality with the Newcastle-Ottawa Scale.
Key Points:
- Analyzed 19 studies involving 1494 COVID-19 patients treated with ECMO.
- Pooled survival probability was determined to be 66.0%.
- Identified pooled morbidities: renal injury (44.0%), venous thrombosis (31.0%), heart failure (14.0%), liver failure (13.0%), pulmonary embolism (11.0%), pneumothorax (9.0%), pulmonary hemorrhage (9.0%), intracranial hemorrhage (8.7%), intracranial thrombosis (7.0%), gastrointestinal hemorrhage (6.0%), and gastrointestinal ischemia (6.0%).
Conclusions:
- This meta-analysis provides crucial data on survival and complication rates for COVID-19 patients on ECMO.
- Findings aid in evaluating the role of ECMO in managing severe COVID-19.
- Results establish a foundation for future research into ECMO therapy for COVID-19.
Background:
The Coronavirus Disease 2019 (COVID-19) pandemic has been ongoing for over 3 years, during which numerous clinical and experimental studies have been conducted. The objective of this systematic review and meta-analysis was to assess the survival probability and complications of COVID-19 patients receiving extracorporeal membrane oxygenation (ECMO).
Methods:
We searched the databases by using Population-Intervention-Comparison-Outcome-Study Design (PICOS). We conducted a search of the PubMed, Web of Science, and EMBASE databases to retrieve studies published until December 10, 2022. A random-effects meta-analysis, subgroup analysis, and assessed the studies using the Newcastle-Ottawa Scale score. The results were presented as pooled morbidity with 95% confidence intervals.
Results:
The study was conducted on 19 studies that enrolled a total of 1494 patients, and the results showed a pooled survival probability of 66.0%. The pooled morbidity for intracranial hemorrhage was 8.7%, intracranial thrombosis 7.0%, pneumothorax 9.0%, pulmonary embolism 11.0%, pulmonary hemorrhage 9.0%, heart failure 14.0%, liver failure 13.0%, renal injury 44.0%, gastrointestinal hemorrhage 6.0%, gastrointestinal ischemia 6.0% and venous thrombosis 31.0%.
Conclusion:
This systematic review and meta-analysis of observational studies focused on the survival probability and complications of COVID-19 patients undergoing ECMO, which are significant in evaluating the use of ECMO in COVID-19 patients and provide a basis for further research.
Trial Registration:
Our study was registered on PROSPERO with registration number CRD42022382555.
More Related Videos
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Related Concept Videos
Endotracheal Tube Extubation
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Acute Respiratory Failure-III
Acute Respiratory Failure-IV